World of Bacteria header image

Aeromonas veronii

Aeromonas veronii is an oxidase-positive, facultatively anaerobic Gram-negative rod associated with aquatic environments. It is one of the Aeromonas species most frequently recovered from human clinical material and may be involved in gastrointestinal, wound, bloodstream, hepatobiliary, and occasionally urinary tract infections.

Basic Characteristics

Taxonomy

  • Domain: Bacteria
  • Phylum: Pseudomonadota (Proteobacteria)
  • Class: Gammaproteobacteria
  • Order: Aeromonadales
  • Family: Aeromonadaceae
  • Genus: Aeromonas
  • Species: Aeromonas veronii

Microscopy & Gram Stain

  • Gram-negative rods
  • Cells usually occur singly or in pairs
  • Motile by means of polar flagella; microscopic morphology is not species-specific

Oxygen Relationship

  • Facultatively anaerobic
  • Grows readily under routine aerobic culture conditions

Rapid Identification Tests

  • Oxidase: positive
  • Catalase: positive
  • Motility: usually positive
  • Indole: usually positive
  • Glucose metabolism: fermentative
  • Haemolysis on blood agar: frequently beta-haemolytic, but variable between isolates

Ecology and Clinical Relevance

Natural Habitat

  • Freshwater, brackish water, and aquatic sediments
  • Fish and other aquatic animals
  • Sewage, soil, and water-associated environmental niches
  • Occasionally present in the gastrointestinal tract of humans and animals

Common Clinical Specimens

  • Stool and other gastrointestinal specimens
  • Wound and soft-tissue specimens after water exposure
  • Blood cultures and hepatobiliary specimens
  • Urine and catheter-associated urinary specimens, although urinary infection is uncommon
  • Other localized specimens, including respiratory and ear material

Clinical Significance

  • Associated with gastroenteritis, although recovery from stool must be interpreted with the clinical findings and exclusion of other enteric pathogens
  • May cause wound and soft-tissue infection following exposure to freshwater or contaminated environments
  • Can cause bacteraemia, sepsis, hepatobiliary infection, and other invasive disease, particularly in patients with underlying illness or impaired host defences
  • Urinary tract infection is uncommon but has been documented, especially in patients with predisposing factors or urinary devices

Differential Considerations

  • Aeromonas hydrophila, A. caviae, and A. dhakensis
  • Vibrio species and Plesiomonas shigelloides
  • Pseudomonas aeruginosa and other oxidase-positive Gram-negative rods
  • Enterobacterales, which are usually oxidase-negative
  • Helpful preliminary clues include oxidase positivity, glucose fermentation, motility, aquatic association, and frequently visible beta-haemolysis

Diagnostic and Clinical Notes

Aeromonas veronii is an aquatic Gram-negative organism and one of the Aeromonas species commonly recovered from human clinical material. Human exposure may occur through contaminated water, food, aquatic animals, or direct inoculation of damaged tissue.

The illustrated isolate was recovered from a urine specimen in mixed culture with Klebsiella pneumoniae. Urinary tract infection due to Aeromonas is uncommon, so clinical interpretation should consider symptoms, quantitative growth, specimen quality, accompanying organisms, and predisposing factors such as urinary instrumentation or underlying disease.

Prominent beta-haemolysis makes the A. veronii colonies visually distinct from the non-haemolytic, hypermucoid K. pneumoniae colonies in this culture. Haemolysis and colony texture are useful descriptive clues but do not provide definitive species identification or establish pathogenic significance.

Historical literature frequently used the designations A. veronii biovar sobria and A. veronii biovar veronii. Modern identification increasingly treats A. veronii at the species level, while older biovar terminology may still appear in clinical and epidemiological publications.

Species-level identification within the genus can be difficult. MALDI-TOF MS and automated biochemical methods are useful when their reference databases are current, but sequencing of discriminatory housekeeping genes or genome-based analysis may be required for unusual, invasive, or epidemiologically important isolates.

Laboratory Identification

Colony Morphology

On blood agar after 18–24 hours at approximately 35–37 °C, Aeromonas veronii commonly forms smooth, convex, grey-white colonies that may be surrounded by clear beta-haemolysis. Colony size, pigmentation, and haemolytic intensity vary between isolates and are not sufficient for species identification.

Microscopy

Gram staining shows Gram-negative rods occurring mainly singly or in pairs. The microscopic appearance overlaps with many other Gram-negative bacteria and cannot distinguish A. veronii from related Aeromonas species.

Key Identification Clues

  • Gram-negative, facultatively anaerobic rod
  • Oxidase positive, unlike Enterobacterales
  • Usually motile, catalase positive, and indole positive
  • Ferments glucose
  • Frequently beta-haemolytic on blood agar
  • Aquatic association and recovery from gastrointestinal, wound, bloodstream, hepatobiliary, or occasional urinary specimens

Modern Identification Methods

Routine identification may be achieved by MALDI-TOF mass spectrometry with an up-to-date database or validated automated biochemical systems. Difficult isolates may require sequencing of genes such as rpoB, gyrB, or rpoD, or whole-genome analysis, because 16S rRNA sequencing and older phenotypic systems may not reliably separate closely related Aeromonas species.

Antibiotic Characteristics

Aeromonas veronii commonly possesses chromosomal beta-lactamases and is usually resistant to ampicillin and several older beta-lactam agents.

Susceptibility to extended-spectrum cephalosporins, fluoroquinolones, trimethoprim-sulfamethoxazole, aminoglycosides, carbapenems, and other potentially active drugs varies between isolates.

Some strains may carry inducible cephalosporinases, metallo-beta-lactamases, or acquired resistance determinants, and resistance may emerge or become apparent during therapy with selected beta-lactam agents.

Note: Clinically significant urinary, wound, bloodstream, hepatobiliary, and other invasive isolates should undergo antimicrobial susceptibility testing using an appropriate validated method. Treatment should be selected according to the individual result and clinical context.

External Resources

For broader information about Aeromonas veronii, aquatic ecology, human infection, laboratory identification, and current taxonomy, see: